Search research articles
Contact Us
Filters
Showing results (101-110 of 121) with videos related to
Page
of 13
Sort By:
Onkologie
|
July 7, 2001
Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II Trial
G. Hartung, R. Hofheinz, D. Buchheidt, et al.
Blood
|
December 15, 1994
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group
R Hehlmann, H Heimpel, J Hasford, et al.
Onkologie
|
February 1, 1987
[Prospective controlled study of therapy of chronic myeloid leukemia (CML)]
R Hehlmann, H Heimpel, D K Hossfeld, et al.
Klinische Wochenschrift
|
February 15, 1984
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum
D Fritze, B Massner, R Becher, et al.
Onkologie
|
April 1, 1987
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)"
H Flechtner, W Queisser, M E Heim, et al.
Deutsche Medizinische Wochenschrift (1946)
|
December 7, 1979
[Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)]
A C Mayr, H J Senn, W M Gallmeier, et al.
Onkologie
|
November 6, 2001
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer
G Hartung, R D Hofheinz, A Wein, et al.
British Journal of Haematology
|
April 1, 1997
Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. German chronic myeloid leukaemia (CML)-Study Group
R Hehlmann, H Ansari, J Hasford, et al.
Deutsche Medizinische Wochenschrift (1946)
|
August 31, 1979
[A prospective multi-centre study of the response of metastatic gastrointestinal tumours (author's transl)]
W Queisser, J Schaefer, H Arnold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 1999
Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society
G Hartung, G Stehle, H Sinn, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 121) with videos related to
Sort By:
Page
of 13
Onkologie
|
July 7, 2001
Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II Trial
G. Hartung, R. Hofheinz, D. Buchheidt, et al.
Blood
|
December 15, 1994
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group
R Hehlmann, H Heimpel, J Hasford, et al.
Onkologie
|
February 1, 1987
[Prospective controlled study of therapy of chronic myeloid leukemia (CML)]
R Hehlmann, H Heimpel, D K Hossfeld, et al.
Klinische Wochenschrift
|
February 15, 1984
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum
D Fritze, B Massner, R Becher, et al.
Onkologie
|
April 1, 1987
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)"
H Flechtner, W Queisser, M E Heim, et al.
Deutsche Medizinische Wochenschrift (1946)
|
December 7, 1979
[Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)]
A C Mayr, H J Senn, W M Gallmeier, et al.
Onkologie
|
November 6, 2001
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer
G Hartung, R D Hofheinz, A Wein, et al.
British Journal of Haematology
|
April 1, 1997
Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. German chronic myeloid leukaemia (CML)-Study Group
R Hehlmann, H Ansari, J Hasford, et al.
Deutsche Medizinische Wochenschrift (1946)
|
August 31, 1979
[A prospective multi-centre study of the response of metastatic gastrointestinal tumours (author's transl)]
W Queisser, J Schaefer, H Arnold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 1999
Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society
G Hartung, G Stehle, H Sinn, et al.
Page
of 13